Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Beauty & Personal Care — Distribution - Perfume & Cosmetics. Per the activity note to the FY2024 annual report, the company imports and distributes hygiene products.
| Ratio | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Margins | ||||
| Gross Margin | 15.3% | 32.0% | 15.5% | N/A |
| EBITDA Margin | -8.6% | 4.9% | 10.7% | N/A |
| EBITDAR | -501 | 1,256 | 297 | -2 |
| EBITDAR Margin | -8.5% | 7.9% | 10.7% | N/A |
| EBIT Margin | -8.7% | 3.5% | 10.7% | N/A |
| Net Profit Margin | -14.4% | -0.1% | 47.1% | N/A |
| Operating Expense % of Sales | 23.9% | 27.0% | 4.8% | N/A |
| Returns | ||||
| Return on Assets (ROA) | -17.1% | -0.2% | 9.0% | -18618.7% |
| Return on Equity (ROE) | N/A | -0.3% | 17.3% | -18618.7% |
| ROIC [EBIT / Invested Capital] | -13.3% | 5.3% | 4.0% | -12.3% |
| Leverage & debt balances | ||||
| Debt-to-Assets | 98.5% | 41.1% | 0.0% | 0.0% |
| Debt-to-Equity | -5.82x | 0.76x | 0.00x | 0.00x |
| Debt-to-EBITDA | N/A | 6.47x | 0.00x | N/A |
| Equity-to-Assets | -16.9% | 54.1% | 52.2% | 100.0% |
| Net Debt | 4,670 | 3,818 | -205 | -2 |
| Cash & Equivalents | 200 | 1,244 | 205 | 2 |
| Total Debt | 4,870 | 5,062 | N/A | N/A |
| Liquidity & working capital | ||||
| Current Ratio | 0.85x | 2.36x | 2.09x | N/A |
| Quick Ratio | 0.85x | 2.36x | 2.09x | N/A |
| Cash Ratio | 0.03x | 0.26x | 0.03x | N/A |
| Total Current Assets | 4,902 | 11,344 | 14,461 | 18 |
| Total Current Liabilities | 5,779 | 4,816 | 6,917 | N/A |
| Inventory | N/A | N/A | N/A | N/A |
| Trade Receivables | 3,927 | 5,189 | N/A | N/A |
| Trade Payables | 656 | 577 | 11 | N/A |
| Net Working Capital | -876 | 6,528 | 7,543 | 18 |
| Net Working Capital % of Revenue | -14.9% | 41.3% | 272.2% | N/A |
| Trade Working Capital | 3,272 | 4,612 | -11 | N/A |
| Trade Working Capital % of Revenue | 55.6% | 29.1% | -0.4% | N/A |
| Change in Trade Working Capital | N/A | 1,340 | -4,623 | 11 |
| Turnover & efficiency | ||||
| Inventory Turnover | N/A | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A | N/A | N/A |
| Receivables Turnover | 1.50x | 3.05x | N/A | N/A |
| Days Sales Outstanding (DSO) | 243.8 | 119.7 | N/A | N/A |
| Payables Turnover | 7.59x | 18.65x | 207.30x | N/A |
| Days Payable Outstanding (DPO) | 48.1 | 19.6 | 1.8 | N/A |
| Cash Conversion Cycle | 195.8 days | 100.1 days | -1.8 days | N/A |
| Asset Turnover | 1.19x | 1.28x | 0.19x | 0.00x |
| Cash flow & dividends | ||||
| Operating Cash Flow | -4,595 | -3,097 | 10,511 | 455 |
| Free Cash Flow (OCF − Capex proxy) | -4,639 | -3,763 | 4,447 | 455 |
| Cash Conversion (OCF / EBITDA) | N/A | -395.7% | 3540.7% | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →